Member Info for CHELSEA7

Which probably means an RNS any time between 11,00 and 12.00. I n the case of a "YES" vote, and after 2 blue 3% rises, level 2 is gearing up for 15p to be passed quickly and then we will see how soon we can get back to 18p.

Putting in another £5k was something i thought long and hard about, believe me, but just 25% excess shares puts me back to 230k something I feel comfortable with. I nteresting that a few have commented £25m is enough for now, but surely we don"t know that without plans at the AGM for how it will be spent yet, and maybe is taking into account a further delay with SCIB1 trial. Looking forward to the recording of the AGM on the 9th November even more. Good luck till tomorrow.

10.00 tomorrow it is...........................

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces that the General Meeting convened for today at 10:00 a.m. at John Eccles House, Robert Robinson Avenue, Oxford Science Park, Oxford OX4 4GP has been adjourned for exactly one week and will resume at 10:00 a.m. on 5 November 2020 at the same location.

GN

Something I appreciate using H/L but don"t know what other platforms do is this message....................

HL logo HL logo

Voting Instruction Received

Dear Mr

A secure message is waiting in your account now.

A few people have posted they are not sure whether their instructions have been acted upon.

Botski, from the RNS on 29th October..............

Arrangements for the Open Offer

The Open Offer closed for receipt of applications at 11:00 a.m. on 28 October 2020 in accordance with its terms and was significantly oversubscribed. The Open Offer remains conditional on the passing of the relevant Resolutions at the adjourned General Meeting and Second Admission becoming effective by 8:30 a.m. on 6 November 2020. Subject to the satisfaction of these conditions, it is expected that:

- Second Admission will become effective, and dealings for normal settlement in the Open Offer Shares will commence, at 8:00 a.m. on 6 November 2020;



- the Open Offer Shares to be held in uncertificated form would be credited to CREST members' CREST Stock Accounts on 6 November 2020;

16:00:18 14.98 45,821 6,864 O
15:56:28 14.98 7,259 1,087 O
15:01:07 14.95 18,000 2,691 O
13:50:19 15.00 113,276 16.99k O
14:30:40 14.95 25,000 3,738 O
10:30:09 14.90 25,000 3,725 O

Again IMHO all of these trades are buys, totalling about 225k.

LL, I don"t trade any other shares TBH, and when I do trade here I am hard pushed to do more than 4 a month, top whack, so I pay £11.95 to use H/L. I just find them very quick to assist in running my account, and was particularly impressed how easy it was to cast my votes last Thursday. I cant compare other companies as I have never used them.

Another buy showing as a sell, sells will be around the 14.75/14.77 Mark.

LL, have to praise you for the research you choose to undertake, I find it very helpful. ATB

1 showing black, 2 showing sells..................

Time Trade Price Volume Value
15:01:07 14.95 18,000 2,691 O
13:50:19 15.00 113,276 16.99k O
14:30:40 14.95 25,000 3,738 O

All buys IMHO

Good Morning!!

14.50/15.50

+3.45%

Agree with Redmile firing on all cylinders, as I posted below Martin Diggle sold just under 2m back in April at 8p. I don"t think Scancell or here knew of Redmiles interest then, relevance being we hear these deals take money months to finalise and whether it is a lot of money to them, or not, it is a lot of money, certainly to us. In the months after we were awarded the INNOVATE funding for £2.9m and appointed manufactures for the vaccine. I think many of us would love to know when the cancer trials will re open, but reading this from the October 2nd RNS reminds me of the high hopes we and others have for COVIDITY, even more valuable as developments now think antibodies created by the treatments of Big Pharma have a shelf life of only 4 months, dereasing quickly in the over 60 age group. To remind...................

2 October 2020



""Cobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell's COVID-19 vaccine in 2021



The collaboration will ensure GMP production of material for the Phase 1 clinical trial of Scancell's DNA vaccine against SARS-CoV-2



Oxford and Keele, UK, 2 October 2020. Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and Scancell Holdings plc (Scancell), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announced that they have entered into a collaboration for Cobra to manufacture Scancell's COVID-19 vaccine. The agreement covers Good Manufacturing Pracatice (GMP) production of plasmid DNA needed to generate the DNA vaccine, against SARS-CoV-2, for use in a Phase 1 clinical trial in 2021 (COVIDITY). The project is funded by an Innovate UK grant awarded to the consortium between Scancell, the University of Nottingham and Trent University, as previously announced in August 2020.



Scancell's DNA vaccine will target the SARS-CoV-2 nucleocapsid (N) protein plus the key receptor binding domain of the spike (S) protein to generate both T cell responses and virus neutralising antibodies against the SARS-CoV-2 virus. This new vaccine has the potential to provide long lasting immunity against COVID-19 by generating protection not only against this strain, but also against new strains of coronavirus that may arise in the future.""

The interest from UK Government seems IMHO to have increased Redmiles interest after the 2.9m funding and I asked earlier what value might be attached to our vaccine. A very speculative question,but the more I dig, the more I think COVIDITY is one of the drivers behind their interest and news flow could well drive this past the 20p you mention. Then we have the result of the adjournment quickly followed by the AGM where we expected to hear news on many issues which will hopefully see us back into cancer trials end H1 2021. I think the importance to us of COVIDITY has been understated but could well be driving

17:05:45 14.50 205,000 29.73k

Well a black Trade, likely to be a sell, and probably needed for tomorrow, LOL

GN

Lol, even Martin Diggle can"t call it right........................what chance do we???

13k

Doubtful Redmiles intentions were known back when they sold.....................

28-Apr-20 27-Apr-20 Sell Martin Diggle 8.00 GBX 1,500,000 79,049,311
27-Apr-20 24-Apr-20 Sell Martin Diggle 8.00 GBX 500,000 80,549,311
17-Dec-19 16-Dec-19 Buy Martin Diggle 5.20 GBX 2,925,000 80,549,311

14/15 + 5.45%

14.70 been paid twice

I just wonder how much value has been attached to COVIDITY, the funding from INNOVATE came about 5 weeks fter Redmile showed their hand, and just a similar time gap followed before Redmile decided on the 2nd tranche at 13p??

Ruck thanks, well we know from here 3 PIs who hold 15m shares and are voting YES, so that should swing it too.

RedCo I, L.P.

Redmile Biopharma Investments II, L.P.

Redmile Capital Offshore Fund (ERISA), Ltd.

Redmile Strategic Master Fund, LP

Redmile Capital Offshore II Master Fund, Ltd.

Redmile Capital Offshore Master Fund, Ltd.

Redmile Capital Fund, LP

City and country of registered office (if applicable)

San Francisco, USA

5. Date on which the threshold was crossed or reachedvi:

02/11/2020

6. Date on which issuer notified (DD/MM/YYYY):

03/11/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

29.97

N/A

29.97

791,917,828

Position of previous notification (if

applicable)

25.48

N/A

25.48

Well SCAP were out of the boxes sharp, carrying the ask at 14p, there are 100k shares at 13.7 on level 2, and it has a look about it that should see a few early tick ups.

Yeah that is how I feel too Rats, anything that aids this journey to arrive at NASDAQ in 2/3 years time would have my support.

I would agree with you, but want to make this point clear, I hope the situation will be OK for the benefit of all. I am very grateful to Vulpes for what they have done for us, which directly or not has come to this. But I am looking at the time when they sold 1.9m shares through different eyes, and I just wonder in view of Redmiles financial backing what role Vulpes have to offer??

They have created a divide on a very important issue, so lets see how that evolves, but looking like crumbs did at many deals Redmile have been involved with certain names come up more often than not as fellow iis, and if they were to want to cash in their holding, they have done pretty well so far, I would hope another ii with considerable influence in this idustry were to replace them. S o it is not something I seek, just something I have considered and perhaps with regard to AB should have made clearer last week.